Schrödinger, Inc. (SDGR )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol SDGR
- Company Schrödinger, Inc.
- Price $30.24
- Changes Percentage 26.37
- Change 6.31
- Day Low $24.09
- Day High $30.41
- Year High $23.02
- Year Low $10.95
- Market Cap $1,472,745,470
- Price Avg 50 EMA (D) $16.38
- Price Avg 200 EMA (D) $15.02
- Exchange NASDAQ
- Volume 1,082,770
- Average Volume 1,267,490
- Open $24.09
- Previous Close $23.93
- EPS -0.74
- PE -26.64
- Earnings Announcement 2026-11-04 05:00:00
- Shares Outstanding $74,720,724
Company brief: SCHRöDINGER, INC. (SDGR )
- Healthcare
- Medical - Healthcare Information Services
- Dr. Ramy Farid Ph.D.
- https://www.schrodinger.com
- US
- N/A
- 02-06-2020
- US80810D1037
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.